Growth Metrics

BeOne Medicines (ONC) Raw Materials (2024 - 2025)

BeOne Medicines (ONC) has disclosed Raw Materials for 2 consecutive years, with $236.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Raw Materials rose 38.46% to $236.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $236.2 million, a 38.46% increase, with the full-year FY2025 number at $236.2 million, up 38.46% from a year prior.
  • Raw Materials was $236.2 million for Q4 2025 at BeOne Medicines, up from $170.6 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $236.2 million in Q4 2025 to a low of $170.6 million in Q4 2024.